Title |
Microvesicles: What is the Role in Multiple Sclerosis?
|
---|---|
Published in |
Frontiers in Neurology, May 2015
|
DOI | 10.3389/fneur.2015.00111 |
Pubmed ID | |
Authors |
Tiziana Carandini, Federico Colombo, Annamaria Finardi, Giacomo Casella, Livia Garzetti, Claudia Verderio, Roberto Furlan |
Abstract |
Microvesicles are a recently described way of cell communication that has been implicated in a number of biological processes, including neuroinflammation. Widely investigated as biomarkers in oncology and neurological disorders, little is known of the role of microvesicles in the pathogenesis of diseases such as multiple sclerosis (MS). Several evidences suggest that pro-inflammatory microglia and infiltrating macrophages release microvesicles that spread inflammatory signals and alter neuronal functions. We review here available information on microvesicles, with a special focus on microglia and macrophage microvesicles, in the pathogenesis of MS, and as potential biomarkers and therapeutic targets. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Mexico | 1 | 1% |
Unknown | 79 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 18 | 23% |
Student > Master | 11 | 14% |
Researcher | 10 | 13% |
Student > Bachelor | 7 | 9% |
Other | 5 | 6% |
Other | 14 | 18% |
Unknown | 15 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 22 | 28% |
Neuroscience | 13 | 16% |
Biochemistry, Genetics and Molecular Biology | 11 | 14% |
Medicine and Dentistry | 10 | 13% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 4% |
Other | 7 | 9% |
Unknown | 14 | 18% |